A number of anticancer approaches attempting to kill tumor cells by phagocytosis, antibody-dependent cell-mediated cytotoxicity, or PCD have relied on CD47 targeting by specific mAbs [15,20,64–66]. The gene discussed is CD47; the disease is neoplasm.